Long-term efficacy of ustekinumab with and without concomitant immunosuppressants for Crohn's disease: results from IM-UNITI long-term extension through 2 years

被引：2
|
作者：
Ghosh, S. [1 ]
Kramer, B. C. [2 ]
Gasink, C. [2 ]
Jacobstein, D. [3 ]
Adedokun, O. J. [3 ]
Gao, L. -L. [3 ]
Rutgeerts, P. [4 ]
Sands, B. E. [5 ]
机构：
[1] Univ Birmingham, Birmingham, W Midlands, England
[2] Janssen Sci Affairs LLC, Horsham, PA USA
[3] Janssen Res & Dev LLC, Spring House, PA USA
[4] Univ Hosp Gasthuisberg, Leuven, Belgium
[5] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
来源：
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词：
D O I：
10.1093/ecco-jcc/jjy222.804
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P680
引用
收藏
页码：S459 / S460
页数：2
相关论文
共 50 条
  • [31] Long-term Efficacy and Safety of Risankizumab in Patients With Moderate to Severe Crohn's Disease up to 3 Years of Treatment: Results From the FORTIFY Open-Label Long-term Extension
    Ferrante, M.
    Panaccione, R.
    Colombel, J. F.
    Dubinsky, M.
    Hisamatsu, T.
    Lindsay, J. O.
    Song, A.
    Neimark, E.
    Zhang, Y.
    Kligys, K.
    Crowley, J.
    Duan, W. R.
    D'Haens, G.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I167 - I169
  • [32] Long-Term Evaluation of Intensified Ustekinumab in Crohn's Disease: Real-Life Results
    Molina Arriero, G.
    Gonzalez Furelos, T.
    Mauriz Barreiro, V.
    Echarri Piudo, A.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1039 - I1039
  • [33] Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension
    Abreu, Maria T.
    Rowbotham, David S.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Tikhonov, Ilia
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Scherl, Ellen J.
    Leong, Rupert W.
    Arasaradnam, Ramesh P.
    Afif, Waqqas
    Peyrin-Biroulet, Laurent
    Sands, Bruce E.
    Marano, Colleen
    JOURNAL OF CROHNS & COLITIS, 2022, 16 (08): : 1222 - 1234
  • [34] Long-Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long-Term Extension of the BENEFIT Study
    Rostaing, L.
    Vincenti, F.
    Grinyo, J.
    Rice, K. M.
    Bresnahan, B.
    Steinberg, S.
    Gang, S.
    Gaite, L. E.
    Moal, M-C
    Mondragon-Ramirez, G. A.
    Kothari, J.
    Pupim, L.
    Larsen, C. P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (11) : 2875 - 2883
  • [35] Long term efficacy and safety of ustekinumab in patients with moderate to severe psoriasis through 5 years of follow-up: results from the PHOENIX 1 long-term extension
    Papp, K.
    Kimball, A.
    Wasfi, Y.
    Chan, D.
    Bissonnette, R.
    Sofen, H.
    Yeilding, N.
    Li, S.
    Szapary, P.
    Gordon, K.
    JOURNAL OF DERMATOLOGY, 2012, 39 : 239 - 240
  • [36] Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long-term extension period of STARDUST
    Peyrin-Biroulet, Laurent
    Vermeire, Severine
    D'Haens, Geert
    Panes, Julian
    Dignass, Axel
    Magro, Fernando
    Nazar, Maciej
    Le Bars, Manuela
    Lahaye, Marjolein
    Ni, Lioudmila
    Bravata, Ivana
    Lavie, Frederic
    Daperno, Marco
    Lukas, Milan
    Armuzzi, Alessandro
    Loewenberg, Mark
    Gaya, Daniel R.
    Danese, Silvio
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (02) : 175 - 185
  • [37] Long-Term Efficacy of Vedolizumab Therapy for Crohn's Disease
    Hanauer, Stephen
    Rutgeerts, Paul
    Xu, Jing
    Rubin, David
    Smyth, Michael
    Abhyankar, Brihad
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S479 - S479
  • [38] REAL-WORLD LONG-TERM EFFECTIVENESS OF USTEKINUMAB IN CROHN'S DISEASE: RESULTS FROM THE ENEIDA REGISTRY
    Iborra, Marisa
    Beltran, Belen
    Fernandez-Clotet, Agnes
    Flores, Eva Iglesias
    Cortes, Pablo Navarro
    Rivero, Montserrat
    Gutierrez, Ana
    Sierra-Ausin, Monica
    Mesonero, Francisco
    Ferreiro, Rocio
    Hinojosa, Joaquin
    Calvet, Xavier
    Sicilia, Beatriz
    Gonzalez-Munosa, Carlos
    Antolin, Beatriz
    Gonzalez, Maria
    Lopez, Ana Y. Carbajo
    Garcia-Lopez, Santiago
    Cardona, Albert Martin
    Suris, Gerard
    Arranz, Maria Dolores A. Martin
    De Francisco, Ruth M.
    Canete, Fiorella
    Samso, Carlos Taxonera
    Gomollon, Fernando
    Lorente, Rufo
    Rodriguez-Lago, Iago
    Fores-Bosh, Ana
    Bernardos, Esther
    Ramos, Laura
    Delgado-Guillena, Pedro
    Camba, Alejandro Hernandez
    Van Domselaar, Manuel
    Hervas, David
    Domenech, Eugeni
    Nos, Pilar
    GASTROENTEROLOGY, 2020, 158 (06) : S953 - S953
  • [39] Methotrexate in Crohn's disease:: long-term efficacy and toxicity
    Lémann, M
    Zenjari, T
    Bouhnik, Y
    Cosnes, J
    Mesnard, B
    Rambaud, JC
    Modigliani, R
    Cortot, A
    Colombel, JF
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (07): : 1730 - 1734
  • [40] EFFICACY AND SAFETY OF INFLIXIMAB IN THE LONG-TERM IN CROHN'S DISEASE
    Fries, W.
    Privitera, A. C.
    Lo Presti, M. A.
    Mastronardi, M.
    Cappello, M.
    Grossi, L.
    Lauria, A.
    Principi, M.
    Della Valle, N.
    Buccianti, N.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S134 - S134
12345